Homo sapiens (human)

Summary
Taxonomy ID
9606
PubChem Taxonomy
9606
Displaying entries 2001 - 2025 of 2090 in total
Pathway Name Protein Name ▲ UniProt ID Gene Symbol GlyTouCan ID
Regulation of PAK-2p34 activity by PS-GAP/RHG10
  • ARHGAP10
  • GRAF2
  • PAK2
RPIA deficiency: failed conversion of R5P to RU5P
  • RPI
  • RPIA
RPIA deficiency: failed conversion of RU5P to R5P
  • RPI
  • RPIA
PRPP biosynthesis
  • PRPS1
  • PRPS1L1
  • PRPS2
  • PRPS3
  • PRPSL
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling
  • ISPK1
  • MAPKAPK1A
  • MAPKAPK1B
  • MAPKAPK1C
  • RPS6KA1
  • RPS6KA2
  • RPS6KA3
  • RPS6KA6
  • RSK1
  • RSK2
  • RSK3
  • RSK4
SLIT2:ROBO1 increases RHOA activity
  • ARH12
  • ARHA
  • DUTT1
  • MYO9B
  • MYR5
  • RHO12
  • RHOA
  • ROBO1
  • SLIL3
  • SLIT2
Synthesis of wybutosine at G37 of tRNA(Phe)
  • C1orf171
  • C2orf60
  • KIAA0547
  • KIAA1393
  • LCMT2
  • RSAFD1
  • TRM12
  • TRM5
  • TRMT12
  • TRMT5
  • TYW1
  • TYW2
  • TYW3
  • TYW4
  • TYW5
SUMO is conjugated to E1 (UBA2:SAE1)
  • AOS1
  • SAE1
  • SAE2
  • SMT3A
  • SMT3B
  • SMT3C
  • SMT3H1
  • SMT3H2
  • SMT3H3
  • SUA1
  • SUMO1
  • SUMO2
  • SUMO3
  • UBA2
  • UBL1
  • UBLE1A
  • UBLE1B
SUMO is proteolytically processed
  • KIAA1331
  • SENP1
  • SENP2
  • SENP5
  • SMT3A
  • SMT3B
  • SMT3C
  • SMT3H1
  • SMT3H2
  • SMT3H3
  • SUMO1
  • SUMO2
  • SUMO3
  • UBL1
STAT6-mediated induction of chemokines
  • ERIS
  • MITA
  • NAK
  • STAT6
  • STING
  • STING1
  • TBK1
  • TMEM173
Integration of energy metabolism
  • PPP2CA
  • PPP2CB
  • PPP2R1A
  • PPP2R1B
  • PPP2R5D
Defective SLC17A5 causes Salla disease (SD) and ISSD
  • SLC17A5
Reuptake of GABA
  • BGT1
  • GABATR
  • GABT1
  • GABT3
  • GAT1
  • GAT2
  • GAT3
  • SLC6A1
  • SLC6A11
  • SLC6A12
  • SLC6A13
Defective SLC6A5 causes hyperekplexia 3 (HKPX3)
  • GLYT2
  • NET1
  • SLC6A5
Variant SLC6A14 may confer susceptibility towards obesity
  • SLC6A14
Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG)
  • SIT1
  • SLC6A20
  • XT3
  • XTRP3
Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG)
  • SIT1
  • SLC6A20
  • XT3
  • XTRP3
Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)
  • DAT1
  • SLC6A3
Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)
  • DAT1
  • SLC6A3
Defective SLC6A19 causes Hartnup disorder (HND)
  • B0AT1
  • SLC6A19
Defective SLC6A19 causes Hartnup disorder (HND)
  • B0AT1
  • SLC6A19
Defective SLC6A2 causes orthostatic intolerance (OI)
  • NAT1
  • NET1
  • SLC6A2
  • SLC6A5
Type II Na+/Pi cotransporters
  • NPT2
  • NPT2C
  • NPTIIC
  • SLC17A2
  • SLC34A1
  • SLC34A2
  • SLC34A3
Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1)
  • NPT2
  • SLC17A2
  • SLC34A1
Defective SLC34A2 causes PALM
  • SLC34A2

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024